Shopping Cart
- Remove All
![TargetMol](https://newstatic.targetmol.com/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $5,120 | In Stock | |
50 mg | $6,780 | In Stock | |
100 mg | $9,700 | 10-14 weeks |
Description | CPX-351 is a Liposomal-encapsulated combination of daunorubicin and cytarabine for the treatment of newly diagnosed tAML or AML with myelodysplasia-related changes (AML-MRCs). |
Alias | Cytarabine/daunonubicin, Vyxeos, CPX 351, Daunonubicin/cytarabine |
Molecular Weight | 770.74 |
Formula | C36H42N4O15 |
Cas No. | 1256639-86-7 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.